Maureen Mealy from Johns Hopkins Medicine: New Treatments for Neuromyelitis Optica in the Pipeline

Video

While there are no approved treatments currently for neuromyelitis optica there is a considerable amount of work being done to help patients with this rare condition in the future.

While there are no approved treatments currently for neuromyelitis optica, there is a considerable amount of work being done to help patients with this rare condition in the future.

With several clinical trials underway and development moving ahead quickly Maureen A. Mealy, RN, BSN, MSCN, discussed the developments in the field during the annual meeting of the Consortium of Multiple Sclerosis Centers in Maryland.

Recent Videos
Developing Risk Assessment Tools for Viruses in School
Getting Black Men Involved in Their Health Care, Clinical Research
Patient Involvement in Advanced HF Treatment, with Ashley Malliett, DMSc, MPAS, PA-C
Aaron Henry, PA-C, MSHS: Regaining Black Male Patient Trust in the Doctor's Office
How to Adequately Screen for and Treat Cognitive Decline in Primary Care
James R. Kilgore, DMSc, PhD, PA-C: Cognitive Decline Diagnostics
What Should the American Academy of Physician Associates Focus on in 2025?
Danielle O'Laughlin, PA-C, MS: Navigating Long-Term Risks, Family Planning in PCOS
© 2024 MJH Life Sciences

All rights reserved.